DEAR VISITORS, THE NEW WEBSITE IS UNDER CONSTRUCTION, SO WE ASK FOR YOUR UNDERSTANDING IF YOU ENCOUNTER OUT-OF-DATE OR INCORRECT INFORMATION. FOR ALL QUESTIONS, WE ARE AT YOUR DISPOSAL BY PHONE +38131597597 or e-mail address: office@cigota.rs

CLINICAL SIGNIFICANSE OF HUMAN RECOMBINANT TSH IN THE SURVEILLANCE AND TREATMENT OF PATIENT WITH THYROID CARCINOME

CLINICAL SIGNIFICANSE OF HUMAN RECOMBINANT TSH IN THE SURVEILLANCE AND TREATMENT OF PATIENT WITH THYROID CARCINOME

28 Dec, 2004
English
vol. 7, iss. 6
2002
Micić Dragan
Pejković Danica
Thyroid cancer
recombinant human TSH

CLINICAL SIGNIFICANSE OF HUMAN RECOMBINANT TSH IN THE SURVEILLANCE AND TREATMENT OF PATIENT WITH THYROID CARCINOME
Abstract Recombinant human TSH (rhTSH) is an effective and safe alternative to thyroid hormone withdrawal during the post-surgical follow up of papillary and follicular thyroid cancer. Its clinical efficiency for the detection of persistent and recurrent disease is similar to that of thyroid hormone withdrawal. The main purpose for its use is to avoid hypothyroidism.

AttachmentSize
PDF icon Glasnik 6 E 2.pdf10.08 KB
Scroll to Top